Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

WELCOME TO ATTENDO AB (PUBL)'S ANNUAL GENERAL MEETING

Attendo AB (publ) gives notice of its Annual General Meeting to be held at 5:00pm on Thursday, 12 April 2018 at Danderyds gymnasium, Rinkebyvägen 4, Danderyd, Sweden. The convention hall opens for registration to the Annual General Meeting at 4:30pm and before the Annual General Meeting begins coffee and cake is served.Participation Any person is entitled to participate at the Annual General Meeting if they are       entered in the share register maintained by Euroclear Sweden AB on Friday, 6 April 2018; and      have notified the company of their intention to participate at the

IRRAS Provides Update on FDA 510(k) Application of IRRAflow™

- Requests for certain technical clarifications and labeling definition -- Financial targets remain unchanged - San Diego, CA, USA, Munich, Germany and Stockholm, Sweden March 12, 2018 – IRRAS AB (NASDAQ Stockholm: IRRAS), a commercial-stage medical technology company focused on designing, developing, and commercializing innovative solutions for various brain pathologies, announced that it received a response from the U.S. Food and Drug Administration (FDA) regarding the company’s 510(k) application for the approval of IRRAflow™, a CE-marked, fully integrated, closed-circuit medical

Samhällsbyggnadsbolaget i Norden AB issues senior unsecured notes for SEK 250 million

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB” or the ”Company”) issues senior unsecured notes for SEK 250 million at a floating interest rate of Stibor 3m + 365 basis points and final maturity of just over three years. The notes will be issued on 16 March 2018. ”We continue to lower our financial costs as well as strengthening our financial position. The SEK 250 million notes issue is part of this process.” says Ilija Batljan, CEO and founder of Samhällsbyggnadsbolaget i Norden AB. The net proceeds will be deployed towards general corporate purposes. The notes are issued under a

Trading in Pomegranate shares by Board members and executives.

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO ANY U.S. PERSONIn line with company policy, a group of Board members and executives of Pomegranate Investment AB (publ) (“Pomegranate” or the “Company”) have notified the Company of trading in the Company’s shares during the last three business days. OTC trading in the Company’s shares is facilitated by Pareto Securities AB and during the last three working days Board members and executives of the Company have acquired a total of 8,843 shares, corresponding to about 0.2% of the total amount of outstanding shares. Management Comments

ASTRAZENECA PROVIDES UPDATE ON MYSTIC TRIAL TIMELINE

12 March 2018 07:00 GMT AstraZeneca and MedImmune, its global biologics research and development arm, today announced an updated timeline for the final analysis of the Phase III MYSTIC trial of Imfinzi (durvalumab) as monotherapy and in combination with tremelimumab, versus platinum-based standard-of-care (SoC) chemotherapy in previously-untreated patients with metastatic (Stage IV) 1st-line non-small cell lung cancer (NSCLC). MYSTIC is an event-driven clinical trial and continues per protocol. Based on current predictions, the final analysis of overall survival (OS) is now expected

AKER BP ASA ANNOUNCES LAUNCH OF $500 MILLION SENIOR NOTES OFFERING

Aker BP ASA (the “Company”) announced today that it has launched an offering of senior notes (the “Offering”) in an aggregate principal amount of $500 million (the “Notes”). Interest will be payable semi-annually. The interest rate, offering price and other terms will be determined at the time of pricing of the Offering, subject to market conditions. The Company intends to use the net proceeds of the Offering to partially repay (without cancelling) drawn commitments under the Company’s reserves-based lending facility (the “RBL Facility”) and pay the costs, fees and expenses related to the

Skanska invests NOK 566M, about SEK 580M, in a new office project in Oslo, Norway

Skanska invests NOK 566M, about SEK 580M in the office project Parallell in Oslo, Norway, with a total leasable area of 19,500 square meters. The construction contract is worth NOK 418M, about SEK 430 million, which will be included in the Nordic order bookings for the first quarter 2018.The project is located in Lören, Oslo's largest development area, less than three kilometers from the city center, where new housing, offices, green areas and commercial areas are being developed. The area is close to Ring 3 and is easily accessible by public transport, on foot and by bicycle. Parallel

Wilson Therapeutics announces agenda for Capital Markets Day on 21 March 2018

Wilson Therapeutics (publ) is pleased to announce the agenda for its Capital Markets Day to be held in Stockholm on Wednesday 21 March 2018. Members of the senior management team will be joined by Dr. Frederick K. Askari MD, PhD, Associate Professor and Director of the Wilson Disease program at the University of Michigan. The program will include in-depth discussion on Wilson Disease and WTX101 (bis-choline tetrathiomolybdate), a first-in-class copper-protein-binding agent with a unique mechanism of action currently in Phase 3 development for Wilson Disease. Agenda · Welcome and

Nordic Nanovector to Present at the China Healthcare Investing & Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London

Oslo, Norway, 12 March 2018 Nordic Nanovector ASA (OSE: NANO) announces that the company will be presenting at the following upcoming investor conferences: • The China Healthcare Investing & Partnering Symposium (CHIPS) in Hangzhou, China (15-17 March) • Stifel Nordic Healthcare Seminar in London, UK (20 March) The slides presented will be made available on Nordic Nanovector’s website (www.nordicnanovector.com) in the Investor Relations section following the presentations. For further information, please contact: IR enquiries Malene Brondberg, VP, Investor Relations and

2cureX invited to present IndiTreat® and clinical data at ESMO in June 2018

2cureX AB (“2cureX”) announce that it has been invited to present results of the IndiTreat® clinical trial at the ESMO World Congress on Gastrointestinal Cancer 2018 in Barcelona. ESMO (European Society for Medical Oncology) is Europe’s leading medical oncology organisation with more than 18.000 oncology professionals. The IndiTreat® trial is progressing according to plan with the first ten patients enrolled.The clinical trial was launched in Denmark end of October 2017 and will this year be extended to Germany (University Medical Center Hamburg-Eppendorf) and the United Kingdom (Queen

Fund investors acted a bit cautiously in February

In February, investment funds recorded a total net outflow of SEK 1.2 billion. Net withdrawals were made from equity funds, whereas the other fund categories had net deposits. The total fund assets in Sweden increased during the month by SEK 23 billion and amounted at the end of February to a new record-high level, SEK 4 098 billion.Investment funds recorded a total net outflow of SEK 1.2 billion in February. Equity funds had net outflows of SEK 8.2 billion. Money market funds and bond funds, on the other hand, recorded net deposits of SEK 2.6 and 1.1 billion respectively. Also hedge funds

Europe invests to boost the uptake of robotic technologies by start-ups and SMEs

VTT will co-lead an EUR 8 million robotics accelerator as technical coordinator In the next three years, Robot Union will select 40 start-ups that will develop projects, in the field of robotics, which are linked to the manufacturing, agri-food, health and civil infrastructure industries. VTT Technical Research Centre of Finland will be the technical coordinator and lead over 50% of the project activities with FundingBox. There is a clear need to stimulate European start-ups and SMEs in the robotics sector to develop novel and innovative technology with the potential to open new

New Affiliate Site for Online Casinos

The online online casino market is growing fast right now all around the world. Only in the UK a new online casino is launched every week and the competition for new players is incredibly tough. To attract new players, the casinos must either invest heavily in advertising or offer generous welcome bonuses to new playersDue to the wide range of online casinos on the market, comparative websites that drive traffic to casinos have become increasingly popular. A very successful comparison page is CasinoWizard  and they are committed to becoming the world's leading

TVO confirms agreement on Olkiluoto 3 project completion and related disputes

FORTUM CORPORATION STOCK EXCHANGE RELEASE 11 MARCH 2018 AT 19.30 EET Earlier today Teollisuuden Voima Oyj (TVO) confirmed that they have signed a comprehensive settlement agreement with the plant supplier consortium companies Avera NP, Areva GmbH, and Siemens AG, as well as Areva SA concerning the completion of the Olkiluoto 3 EPR (OL3) project and related disputes. The entry into force of the agreement is subject to certain conditions that are currently expected to be met during March 2018. Fortum is participating with a 25% ownership in the building of OL3, a 1,600 MW nuclear power

TVO confirms a settlement agreement signed on OL3 EPR project completion and related disputes

(UPM, Helsinki, 11 March 2018 at 19:30 EET) - Teollisuuden Voima Oyj (TVO) confirms that it has signed a comprehensive settlement agreement concerning the completion of the OL3 EPR project and related disputes with OL 3 EPR (OL3) plant supplier consortium companies Areva NP, Areva GmbH and Siemens AG as well as with Areva Group parent company Areva SA, a company wholly owned by the French State. According to TVO the entry into force of the settlement agreement is subject to certain conditions that are currently expected to be met during March 2018. It is not certain, therefore, that the

TVO confirms a settlement agreement signed on OL3 EPR project completion and related disputes

Teollisuuden Voima Oyj (TVO) notes information that has been made public and confirms that it has signed a comprehensive settlement agreement with Olkiluoto 3 EPR (OL3 EPR) plant supplier consortium companies Areva NP, Areva GmbH and Siemens AG as well as with Areva Group parent company Areva SA, a company wholly owned by the French State. The settlement agreement concerns the completion of the OL3 EPR project and related disputes. The entry into force of the settlement agreement is subject to certain conditions that are currently expected to be met during March 2018. It is not certain,

Innovative Scania excels in patent applications

Scania once again excels in innovation as the leader in patents. In 2017, Scania submitted 243 patent applications to the Swedish Patent and Registration Office, more than any other company in Sweden. Meanwhile, Scania was granted 295 patents last year, by far most in Sweden.“This clearly shows Scania’s innovative capacity,” says Claes Erixon, Head of R&D at Scania. “Our company aims to be the driving force in the shift towards sustainable transport and with this in mind we are constantly developing our services and technologies.” The majority of patent applications are related to

Catella strengthens UK presence by signing a conditioned share purchase agreement to acquire majority stake in APAM Ltd

Catella AB has, through Catella Property Fund Management AB (“CPFM”), signed a share purchase agreement to acquire a majority stake in the leading UK real estate investment and asset management company, APAM Ltd. Closing of the transaction requires regulatory approval and other conditions to be fulfilled.APAM Ltd (“APAM”) has experienced fast growth over recent years and had revenues of approximately GBP 7 million during the calendar year 2017. CPFM has agreed to acquire 75% of the shares in APAM for a price corresponding to GBP 18 million, on a debt and cash free basis. A non-refundable

Samhällsbyggnadsbolaget initiates a written procedure in order to amend the terms and conditions of the outstanding hybrid notes with symbol SAMN 001

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB” or the ”Company”) has today initiated a so called “Written Procedure” under the Company’s subordinated perpetual floating rate notes of up to SEK 1,000,000,000 with ISIN SE0010414599 and symbol SAMN 001 (the "Notes") in accordance with the terms and conditions dated 22 September 2017 (the "Terms and Conditions"). Therefore, the Company has instructed Nordic Trustee & Agency AB (publ) (the ”Agent”) to initiate a Written Procedure in order to formally vote for (i) an amendment of the Terms and Conditions whereby a) the Company's right to

Vessel Acquisition

Oslo, 9 March 2018 - MPC Container Ships ASA (OSE: MPCC, the "Company") is pleased to announce that it has today entered into an agreement to acquire "Francoise Gilot" (tbn "AS Franziska"), a 1,350 TEU vessel built in 2005. The purchase price for the vessel is USD 6.6m. Oslo, 9 March 2018 - MPC Container Ships ASA (OSE: MPCC, the "Company") is pleased to announce that it has today entered into an agreement to acquire "Francoise Gilot" (tbn "AS Franziska"), a 1,350 TEU vessel built in 2005. The purchase price for the vessel is USD 6.6m. Physical takeover of the vessel is expected to

Dignitana, Inc. Appoints Three Board Members in U.S. And Names James McKinney President and Chief Operating Officer

Lund, Sweden – 9 March 2018 – Dignitana AB , world leader in medical scalp cooling technology, today announced the appointment of Anette Cronström, Thomas Joyce and Thomas Kelly to the Board of Directors for Dignitana, Inc., which governs operations in the U.S. and met this week in Dallas, Texas Also announced is the promotion of James McKinney who will now serve as President and Chief Operating Officer of Dignitana, Inc.. McKinney has been the company’s Chief Operating Officer since November 2016. “We are honored to bring these experienced leaders onto

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.03.2018

United Bankers Corporation NOTIFICATION 09.03.2018 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.03.2018 Date 09.03.2018Exchange transaction BuyShare class UNIAVAmount 60Average price/share 35.0000 EURHighest price/share 35.0000 EURLowest price/share 35.0000 EURTotal price 2,100.00 EUR The shares held by United Bankers Corporation on 09.03.2018: UNIAV 9,683 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ) Antti Salakka  Markus

There are no items matching the current filter
There are no more items matching the current filter
Back to top